Experts say diagnosing, managing IBS-M remains challenging: 3 key notes

Providers believe irritable bowel syndrome with mixed diarrhea and constipation is still a challenging disease, Yahoo! Finance reports.

A MedPage Today article cited dietary modification, rifaximin and Boca Raton, Fla.-based IM HealthScience's IBgard as the disease's three effective interventions.

Here are three things to know:

1. Los Angeles-based Cedars-Sinai Medical Center Assistant Director Ali Rezaie, MD, said dietary restriction is a difficult option because "dietary restriction can affect quality of life, sometimes more than the [IBS-M] symptoms themselves."

2. Dr. Rezaie argued alternating laxatives and anti-diarrheal medication complicates the situation.

3. Several providers praised IBgard's ability to treat IBS-M.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast